Literature DB >> 2155533

The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine.

W J Benevento1, P Murray, C A Reed, J S Pepose.   

Abstract

Povidone-iodine is an effective broad-spectrum disinfectant with no reported toxicity to the cornea and conjunctiva when applied topically in single dose to the ocular surface. We challenged four strains of Neisseria gonorrhoeae, a clinical isolate of Chlamydia trachomatis, and one strain of herpes simplex virus type II with three different concentrations of povidone-iodine (5%, 1%, and 0.1%) for one minute. The challenge inoculum of Neisseria gonorrhoeae and herpes simplex virus type II were completely sterilized by all three solutions. The chlamydia titer was reduced by two log units at the 5% and 1% concentrations, but not the 0.1% concentration. Povidone-iodine may be of potential use in the prophylaxis of newborns against ophthalmia neonatorum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155533     DOI: 10.1016/s0002-9394(14)74560-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  A double application approach to ophthalmia neonatorum prophylaxis.

Authors:  S J Isenberg; L Apt; M Del Signore; S Gichuhi; N G Berman
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

Review 2.  Periodic health examination, 1992 update: 4. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

3.  Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.

Authors:  C L Shields; J A Shields; P De Potter; A D Singh
Journal:  Trans Am Ophthalmol Soc       Date:  1993

4.  Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases.

Authors:  C L Shields; J A Shields; P De Potter; A D Singh
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

5.  Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.

Authors:  Christian Clement; Joseph A Capriotti; Manish Kumar; Jeffery A Hobden; Timothy P Foster; Partha S Bhattacharjee; Hilary W Thompson; Rashed Mahmud; Bo Liang; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

6.  Herpetic keratitis in Tanzania: association with malaria.

Authors:  D Yorston; A Foster
Journal:  Br J Ophthalmol       Date:  1992-10       Impact factor: 4.638

7.  A randomised trial of povidone-iodine to reduce visual impairment from corneal ulcers in rural Nepal.

Authors:  J Katz; S K Khatry; M D Thapa; O D Schein; E Kimbrough Pradhan; S C LeClerq; K P West
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

8.  First attempt to implement ophthalmia neonatorum prophylaxis in angola: microorganisms, efficacy, and obstacles.

Authors:  Isabel Alexandre; Mar Justel; Prudencio Martinez; Raul Ortiz de Lejarazu; J Carlos Pastor
Journal:  J Ophthalmol       Date:  2015-02-16       Impact factor: 1.909

9.  A Survey of Current Prophylactic Treatment for Ophthalmia Neonatorum in Croatia and a Review of International Preventive Practices.

Authors:  Snježana Kaštelan; Sonja Anić Jurica; Slavko Orešković; Tomislav Župić; Mislav Herman; Antonela Gverović Antunica; Irena Marković; Ivana Bakija
Journal:  Med Sci Monit       Date:  2018-11-10

10.  Doctor I Have an Iodine Allergy.

Authors:  Michael W Stewart
Journal:  Ophthalmol Ther       Date:  2022-04-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.